Login / Signup

Reliability and validity of composite scores from the timed subtests of the D-KEFS battery.

Yana SuchyStacey L Brothers
Published in: Psychological assessment (2022)
Many neuropsychological tests of executive functioning (EF) have test-retest reliabilities below what is considered acceptable. Combining several tests into a composite can improve reliability, although due to concerns about the multifaceted nature of the EF construct, this practice is rarely applied. The present study (a) examined internal consistencies and test-retest reliabilities of two composites of four EF tests ( EF-Speed from timed scores and EF-Accuracy from error scores), and (b) preliminarily examined the criterion validity of the composites as a first step toward construct validation. Participants were 576 adults aged 18-93. Participants completed timed subtests of the Delis-Kaplan Executive Function System (D-KEFS) at baseline. A subset of participants was retested twice (at 30 min and 1 year), or once (at 6 weeks). An additional subsample completed Timed Instrumental Activities of Daily Living (TIADLs), which was used to preliminarily examine the composites' criterion validity. Internal consistency and test-retest reliabilities ranged from good to excellent for the EF-Speed composite (.809-.901) but were poor to acceptable for the EF-Accuracy composite (.510-.736). Both composites surpassed reliabilities of individual test or condition scores; one third of the examined individual speed-based scores and none of the individual error-based scores met the acceptable reliability threshold (i.e., < .7). The EF-Speed composite accounted for more variance in TIADL speed, and the EF-Accuracy in TIADL accuracy, than did any of the individual test scores, providing preliminary evidence of clinical utility and criterion validity. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Keyphrases
  • reduced graphene oxide
  • healthcare
  • primary care
  • mild cognitive impairment
  • tyrosine kinase
  • preterm birth
  • visible light
  • gestational age
  • adverse drug